• / Free eNewsletters & Magazine
  • / My Account
Home>Agendia Co-Founder and CSO Develops Method to Identify Women Who Will Benefit from Tamoxifen Therapy for Breast Cancer

Agendia Co-Founder and CSO Develops Method to Identify Women Who Will Benefit from Tamoxifen Therapy for Breast Cancer

3party Content

Thu, 31 Jul 2014

Agendia Co-Founder and CSO Develops Method to Identify Women Who Will Benefit from Tamoxifen Therapy for Breast Cancer
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.